QURE Stock Analysis: Buy, Sell, or Hold?
QURE - uniQure N.V.
$27.05
-0.70 (-2.52%)
▼
5d:
-2.21%
30d:
+60.92%
90d:
+31.95%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Smart Money Accumulation
QURE is down 5.9% this week, but smart money is accumulating calls. Top strike: $20 2026-07-17 with 9,841 OI. Call ratio: 93% View Scanner →
Strength: 7.2/10
Get Alerted When QURE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called QURE this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: QURE is 10.1% above its trading range ($24.57). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: QURE is 10.1% above its trading range ($24.57). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: QURE is currently trading at $27.05, which is considered extended relative to its 30-day fair value range of $15.87 to $24.57.
Technical Outlook: Technically, QURE is in a downtrend. Immediate support is located at $19.40, while resistance sits at $29.83.
Market Sentiment: QURE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $39.19 (+44.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, QURE is in a downtrend. Immediate support is located at $19.40, while resistance sits at $29.83.
Market Sentiment: QURE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $39.19 (+44.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$15.87 -
$24.57
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding QURE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+10.1% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 44.9% below Wall St target ($39.19)
Trading Range Analysis
30-Day Trading Range
$15.87 -
$24.57
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$19.40
Resistance Level
$29.83
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.10
Wall Street Target
$39.19
(+44.9%)
Revenue Growth (YoY)
127.3%
Earnings Growth (YoY)
-18.2%
Share & Embed Analysis
Last updated: May 18, 2026 7:32 AM ET
Data refreshes hourly during market hours. Next update: 8:32 AM
Data refreshes hourly during market hours. Next update: 8:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QURE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeannette Potts
SELL
3412 shares
2026-03-04
Matthew C Kapusta
SELL
14581 shares
2026-03-04
Walid Abi-Saab
SELL
808 shares
2026-03-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 55 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 55 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$203 | 52 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 62 BUY |
Advanced QURE Option Strategies
Professional options setups generated by AI based on today's QURE price and gamma walls.
